Brain Cancer Trial, Recruiting (NCT06362304)

Brain Cancer Trial, Recruiting NCT06362304 Sponsor: Peking Union Medical College Hospital Condition: Brain Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06362304 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Brain Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been clinically diagnosed with a brain tumor
People who are at least 18 years old
People whose tumor tissue can be obtained and examined in a laboratory through surgery or biopsy
People who are able to give their consent to participate and are able to attend follow-up appointments
People who do not meet any of the exclusion criteria listed below

Who may not be able to join:

People who have insulin-dependent diabetes, or whose fasting blood sugar level is above 7 mmol/L before receiving the study imaging agent
People with serious liver or kidney disease, based on specific blood test results showing high levels of creatinine or liver enzymes (confirm with trial site)
People who have had a severe allergic reaction to radiocontrast agents (dyes used in medical scans)
People who experience severe anxiety in enclosed spaces (claustrophobia) that would prevent them from undergoing the required medical scans
People who are currently receiving radiotherapy or chemotherapy
People who are pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 01069154241

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06362304

Sponsor: Peking Union Medical College Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Brain Cancer

Trial contact: 01069154241

More information: https://clinicaltrials.gov/study/NCT06362304

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been clinically diagnosed with a brain tumor
People who are at least 18 years old
People whose tumor tissue can be obtained and examined in a laboratory through surgery or biopsy
People who are able to give their consent to participate and are able to attend follow-up appointments
People who do not meet any of the exclusion criteria listed below

Who may not be able to join:

People who have insulin-dependent diabetes, or whose fasting blood sugar level is above 7 mmol/L before receiving the study imaging agent
People with serious liver or kidney disease, based on specific blood test results showing high levels of creatinine or liver enzymes (confirm with trial site)
People who have had a severe allergic reaction to radiocontrast agents (dyes used in medical scans)
People who experience severe anxiety in enclosed spaces (claustrophobia) that would prevent them from undergoing the required medical scans
People who are currently receiving radiotherapy or chemotherapy
People who are pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Peking Union Medical College Hospital

Registry

ClinicalTrials.gov

Start date

20 April 2024

Est. completion

1 February 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

SUVmax

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov